These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38503431)

  • 1. Normalizing Anti-Thrombin III for heparin management during routine cardiopulmonary bypass for congenital cardiothoracic surgery: A single institution practice review.
    Deptula J; Olshove V; Oldeen M; Kozik D; Alsoufi B
    Perfusion; 2024 Mar; ():2676591241239819. PubMed ID: 38503431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update.
    Despotis GJ; Joist JH
    J Cardiothorac Vasc Anesth; 1999 Aug; 13(4 Suppl 1):18-29; discussion 36-7. PubMed ID: 10468245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug, devices, technologies, and techniques for blood management in minimally invasive and conventional cardiothoracic surgery: a consensus statement from the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) 2011.
    Menkis AH; Martin J; Cheng DC; Fitzgerald DC; Freedman JJ; Gao C; Koster A; Mackenzie GS; Murphy GJ; Spiess B; Ad N
    Innovations (Phila); 2012; 7(4):229-41. PubMed ID: 23123988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in heparin dose response slope during cardiac surgery: possible result in inaccuracy in predicting heparin bolus dose requirement to achieve target ACT.
    Ichikawa J; Mori T; Kodaka M; Nishiyama K; Ozaki M; Komori M
    Perfusion; 2017 Sep; 32(6):474-480. PubMed ID: 28820035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation for cardiac surgery in patients receiving preoperative heparin: use of the high-dose thrombin time.
    Shore-Lesserson L; Manspeizer HE; Bolastig M; Harrington D; Vela-Cantos F; DePerio M
    Anesth Analg; 2000 Apr; 90(4):813-8. PubMed ID: 10735781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Titrated versus conventional anticoagulation management for thrombin generation in cardiac surgery: a randomized controlled trial.
    Li H; Bartoszko J; Serrick C; Rao V; Karkouti K
    Can J Anaesth; 2022 Sep; 69(9):1117-1128. PubMed ID: 35799088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin concentration-based anticoagulation for cardiac surgery fails to reliably predict heparin bolus dose requirements.
    Garvin S; FitzGerald DC; Despotis G; Shekar P; Body SC
    Anesth Analg; 2010 Oct; 111(4):849-55. PubMed ID: 19861367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulation of children undergoing cardiopulmonary bypass is overestimated by current monitoring techniques.
    Owings JT; Pollock ME; Gosselin RC; Ireland K; Jahr JS; Larkin EC
    Arch Surg; 2000 Sep; 135(9):1042-7. PubMed ID: 10982508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombin III during cardiac surgery: effect on response of activated clotting time to heparin and relationship to markers of hemostatic activation.
    Despotis GJ; Levine V; Joist JH; Joiner-Maier D; Spitznagel E
    Anesth Analg; 1997 Sep; 85(3):498-506. PubMed ID: 9296400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-level-based anticoagulation management during cardiopulmonary bypass: a pilot investigation on the effects of a half-dose aprotinin protocol on postoperative blood loss and hemostatic activation and inflammatory response.
    Koster A; Huebler S; Merkle F; Hentschel T; Gründel M; Krabatsch T; Tambeur L; Praus M; Habazettl H; Kuebler WM; Kuppe H
    Anesth Analg; 2004 Feb; 98(2):285-290. PubMed ID: 14742356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin management.
    Koster A; Fischer T; Praus M; Haberzettl H; Kuebler WM; Hetzer R; Kuppe H
    Anesthesiology; 2002 Oct; 97(4):837-41. PubMed ID: 12357148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges with heparin-based anticoagulation during cardiopulmonary bypass in children: Impact of low antithrombin activity.
    Manlhiot C; Gruenwald CE; Holtby HM; Brandão LR; Chan AK; Van Arsdell GS; McCrindle BW
    J Thorac Cardiovasc Surg; 2016 Feb; 151(2):444-50. PubMed ID: 26553458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin dose response is independent of preoperative antithrombin activity in patients undergoing coronary artery bypass graft surgery using low heparin concentrations.
    Garvin S; Fitzgerald D; Muehlschlegel JD; Perry TE; Fox AA; Shernan SK; Collard CD; Aranki S; Body SC
    Anesth Analg; 2010 Oct; 111(4):856-61. PubMed ID: 20142342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Change in heparin potency and effects on the activated clotting time in children undergoing cardiopulmonary bypass.
    Guzzetta NA; Amin SJ; Tosone AK; Miller BE
    Anesth Analg; 2012 Oct; 115(4):921-4. PubMed ID: 22822188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of heparin management strategies in infants undergoing cardiopulmonary bypass.
    Guzzetta NA; Bajaj T; Fazlollah T; Szlam F; Wilson E; Kaiser A; Tosone SR; Miller BE
    Anesth Analg; 2008 Feb; 106(2):419-25, table of contents. PubMed ID: 18227295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete heparin-coated (CBAS) cardiopulmonary bypass and reduced systemic heparin dose; effects on coagulation and fibrinolysis.
    Ovrum E; Brosstad F; Am Holen E; Tangen G; Abdelnoor M; Oystese R
    Eur J Cardiothorac Surg; 1996; 10(6):449-55. PubMed ID: 8817142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The treatment of heparin resistance with Antithrombin III in cardiac surgery.
    Kanbak M
    Can J Anaesth; 1999 Jun; 46(6):581-5. PubMed ID: 10391608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial antithrombin-III deficiency during cardiopulmonary bypass: a case report.
    Brinks HJ; Weerwind PW; Verkroost MW; Nováková I; Brouwer MH
    Perfusion; 2000 Nov; 15(6):553-6. PubMed ID: 11131221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin-protamine balance after neonatal cardiopulmonary bypass surgery.
    Peterson JA; Maroney SA; Zwifelhofer W; Wood JP; Yan K; Bercovitz RS; Woods RK; Mast AE
    J Thromb Haemost; 2018 Oct; 16(10):1973-1983. PubMed ID: 30016577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin dose and postoperative bleeding in patients undergoing cardiopulmonary bypass.
    Rosin MW; Holt D
    J Extra Corpor Technol; 2013 Dec; 45(4):228-34. PubMed ID: 24649570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.